Search hospitals
>
Alaska
>
Anchorage
Providence Alaska Medical Center
Claim this profile
Anchorage, Alaska 99508
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Brain Tumor
Conducts research for Breast cancer
332 reported clinical trials
9 medical researchers
Summary
Providence Alaska Medical Center is a medical facility located in Anchorage, Alaska. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Brain Tumor, Breast cancer and other specialties. Providence Alaska Medical Center is involved with conducting 332 clinical trials across 521 conditions. There are 9 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Brenda J. Wittman, and Nitya Alluri.
Area of expertise
Breast Cancer
Providence Alaska Medical Center has run 46 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Providence Alaska Medical Center has run 43 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Alison K. Conlin
Providence Portland Medical Center
7 years of reported clinical research
Charles W. Drescher
Providence Portland Medical Center
9 years of reported clinical research
Brenda J. Wittman
Providence Alaska Medical Center
8 years of reported clinical research
Nitya Alluri
Providence Portland Medical Center
2 years of reported clinical research
Clinical Trials running at Providence Alaska Medical Center
Lung Cancer
Prostate Cancer
Bladder Cancer
Ovarian Cancer
Breast Cancer
Esophageal cancer
Multiple Myeloma
Bladder Carcinoma
Pancreatic Cancer
Breast cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting
2 awards
Phase 3
7 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Providence Alaska Medical Center?
Providence Alaska Medical Center is a medical facility located in Anchorage, Alaska. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Brain Tumor, Breast cancer and other specialties. Providence Alaska Medical Center is involved with conducting 332 clinical trials across 521 conditions. There are 9 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Brenda J. Wittman, and Nitya Alluri.
Where is Providence Alaska Medical Center located?
**Providence Alaska Medical Center** - **Address:** 3200 Providence Drive, Anchorage, AK 99508 - **Directions:** Accessible via Seward Highway; exit onto Providence Drive, hospital will be on the left.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Providence Alaska Medical Center, please contact the Financial Assistance Team at 855-229-6466. For billing customer service regarding clinics and physicians, dial 907-212-6522, and for hospital billing inquiries, call 907-212-6500.
What insurance does Providence Alaska Medical Center accept?
Providence Alaska Medical Center accepts a wide range of insurance plans, including but not limited to Premera, Aetna Medicare Advantage PPO, Anthem Blue Cross HMO/PPO, Blue Shield of CA HMO/PPO, Choice/Humana PPO, Cigna PPO, and United Healthcare PPO. For the most accurate and current information on accepted insurance plans, please contact the hospital directly.
What awards or recognition has Providence Alaska Medical Center received?
Providence Alaska Medical Center, located in Anchorage, Alaska, is honored as a 2023-24 Best Regional Hospital by U.S. News & World Report, excelling in seven types of care. The hospital proudly holds its second Magnet designation, highlighting its commitment to nursing excellence and the positive impact on the community.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.